CARBAMAZEPINE Side Effects

6802914-1 | Dyskinesia, Mood Swings, Tremor
on Jun 15, 2010 Male patient from INDIA , 27 years of age, was diagnosed with mania and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, mood swings, tremor. Carbamazepine dosage: Unk. During the same period patient was treated with LITHIUM (Unk,unk) (View Lithium Review and Lithium Label ).

6800950-2 | Convulsion, Dysarthria, Gait Disturbance, Hyponatraemia, Petit Mal Epilepsy, Pollakiuria, Somnolence
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: convulsion, dysarthria, gait disturbance, hyponatraemia, petit mal epilepsy, pollakiuria, somnolence on Jun 18, 2010 from ITALY Additional patient health information: Male patient , 74 years of age, was diagnosed with convulsion and. Carbamazepine dosage: 100 Mg, Bid. During the same period patient was treated with ATORVASTATIN CALCIUM (Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ), ESOMEPRAZOLE (Unk) (View Esomeprazole Review and Esomeprazole Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ).

6800937-X | Dizziness, Gait Disturbance, Malaise, Nausea
Adverse event was reported on Jun 18, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 800 Mg, Qd) . Location: GERMANY , 49 years of age, After Carbamazepine was administered, patient had the following side effects: dizziness (What is dizziness?), gait disturbance, malaise, nausea (What is nausea?). During the same period patient was treated with OMEPRAZOLE (20 Mg, Qd) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6795038-3 | Blood Folate Increased, Cataract Cortical, Convulsion, Grand Mal Convulsion, Treatment Noncompliance, Visual Acuity Reduced, Vitamin B12 Increased
on Jun 14, 2010 Male patient from KOREA, REPUBLIC OF , 38 years of age, was diagnosed with temporal lobe epilepsy and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: blood folate increased, cataract cortical, convulsion, grand mal convulsion, treatment noncompliance, visual acuity reduced, vitamin b12 increased. Carbamazepine dosage: 600-800 Mg, Per Day. Patient was hospitalized.


6784995-7 | Altered State Of Consciousness, Central Nervous System Lesion, Hypertension, Reversible Posterior Leukoencephalopathy Syndrome, Vasogenic Cerebral Oedema
on Jun 07, 2010 Male patient from JAPAN , 21 years of age, weighting 112.4 lb, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: altered state of consciousness, central nervous system lesion, hypertension, reversible posterior leukoencephalopathy syndrome, vasogenic cerebral oedema. Carbamazepine dosage: 400 Mg; Qd; Po. Patient was hospitalized.

6782651-2 | Device Related Infection, Enterobacter Test Positive, Enterocolitis Infectious, Escherichia Test Positive, Thrombophlebitis Septic, Toxic Epidermal Necrolysis, Venous Occlusion, Wound Infection
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: device related infection, enterobacter test positive, enterocolitis infectious, escherichia test positive, thrombophlebitis septic, toxic epidermal necrolysis, venous occlusion, wound infection on Jun 07, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 52 years of age, was diagnosed with musculoskeletal pain and. Carbamazepine dosage: . Patient was hospitalized.

6781276-2 | Blood Glucose Increased, Coma, Dialysis, Intentional Overdose, Restlessness, Somnolence, Suicide Attempt
Adverse event was reported on Jun 08, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 60 Tablets At Once) . Location: CHINA , 40 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, coma, dialysis (What is dialysis?), intentional overdose, restlessness, somnolence, suicide attempt. Patient was hospitalized.

6774865-2 | Insomnia, Muscle Tightness, Osteomalacia, Pain In Extremity, Restless Legs Syndrome
on Jun 09, 2010 Female patient from INDIA , 16 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: insomnia, muscle tightness, osteomalacia, pain in extremity, restless legs syndrome. Carbamazepine dosage: 200 Mg, Bid.

6774564-7 | Abdominal Pain, Abdominal Tenderness, Acute Hepatic Failure, Alanine Aminotransferase Increased, Anuria, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Urea Increased, Cerebellar Syndrome
on Jun 09, 2010 Male patient from CANADA , 34 years of age, was diagnosed with complex partial seizures, musculoskeletal pain, crohn's disease (What is crohn's disease?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal tenderness, acute hepatic failure, alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, cerebellar syndrome. Carbamazepine dosage: Unk. During the same period patient was treated with ACETAMINOPHEN (2.5 Grams A Day) (View Acetaminophen Review and Acetaminophen Label ), CLOBAZAM (10 Mg Daily) (View Clobazam Review and Clobazam Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ), MESALAZINE (4 G Daily) (View Mesalazine Review and Mesalazine Label ).

6768829-2 | Rhabdomyolysis
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis on May 27, 2010 from FRANCE Additional patient health information: Male patient , 25 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Carbamazepine dosage: 800 Mg;qd. During the same period patient was treated with CLONAZEPAM (6 Mg;qd) (View Clonazepam Review and Clonazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ). Patient was hospitalized.

6768825-5 | Fanconi Syndrome
Adverse event was reported on Jun 01, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 10 Mg/kg (10mg/k G, 1 In 1 D)) . Location: JAPAN , 15 years of age, Patient had the following side effects: fanconi syndrome. During the same period patient was treated with VALPROIC ACID (25 Mg/kg (25 Mg/kg, 1 In 1 D)) (View Valproic Acid Review and Valproic Acid Label ), CLOBAZAM (0.7 Mg/kg (0.7 Mg/kg, 1 In 1 D)) (View Clobazam Review and Clobazam Label ).

6767780-1 | Caesarean Section
on Jun 01, 2010 Female patient from ISRAEL , 31 years of age, was diagnosed with neuralgia and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: caesarean section. Carbamazepine dosage: Unk. During the same period patient was treated with AZATHIOPRINE (Unk) (View Azathioprine Review and Azathioprine Label ).

6767769-2 | Brain Oedema, Coma, Conjunctival Oedema, Haemoperfusion, Hyporeflexia, Hypotonia, Liver Function Test Abnormal
on May 31, 2010 Male patient from CHINA , 68 years of age, was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, coma, conjunctival oedema, haemoperfusion, hyporeflexia, hypotonia, liver function test abnormal. Carbamazepine dosage: 80 Df, Once/single. Patient was hospitalized.

6765532-X | Bone Density Decreased, Convulsion, Headache, Incorrect Dose Administered, Migraine, Nausea, Tooth Disorder, Tooth Fracture
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: bone density decreased, convulsion, headache (What is headache?), incorrect dose administered, migraine (What is migraine?), nausea (What is nausea?), tooth disorder (What is tooth disorder?), tooth fracture on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.0 lb, was diagnosed with grand mal convulsion and. Carbamazepine dosage: 200 Mg Daily, Oral. During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6760041-6 | Abdominal Pain, Anuria, Back Pain, Balance Disorder, Blood Creatinine Increased, Cerebellar Syndrome, Diplopia, Gait Disturbance, Hepatic Failure
Adverse event was reported on May 25, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 1600 Mg, 1600 Mg) was diagnosed with complex partial seizures, back pain (What is back pain?) and. Location: CANADA , 34 years of age, After Carbamazepine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anuria, back pain (What is back pain?), balance disorder, blood creatinine increased, cerebellar syndrome, diplopia, gait disturbance, hepatic failure. During the same period patient was treated with ACETAMINOPHEN (2000 Mg, 2500 Mg) (View Acetaminophen Review and Acetaminophen Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ). Patient was hospitalized.

6759383-X | Nausea, Speech Disorder
on May 26, 2010 Male patient from UNITED STATES , 30 years of age, was diagnosed with tinnitus (What is tinnitus?) and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), speech disorder. Carbamazepine dosage: 400mg Daily 047.

6759061-7 | Amnesia, Convulsion, Underdose
on May 17, 2010 Male patient from UNITED STATES , 18 years of age, weighting 202.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: amnesia, convulsion, underdose. Carbamazepine dosage: 200 Mg Twice Daily, Oral. During the same period patient was treated with MULTIVITAMIN DAILY (View Multivitamin Daily Review and Multivitamin Daily Label ).

6758749-1 | Convulsion, Headache, Nausea, Tooth Disorder, Tooth Injury
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: convulsion, headache (What is headache?), nausea (What is nausea?), tooth disorder (What is tooth disorder?), tooth injury on May 17, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, weighting 115.0 lb, was diagnosed with grand mal convulsion and. Carbamazepine dosage: 200 Mg Daily, Oral. During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

6757820-8 | Insomnia, Muscle Tightness, Osteomalacia, Pain In Extremity, Restless Legs Syndrome
Adverse event was reported on May 25, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: 200 Mg, Bid, For 3 Years) was diagnosed with epilepsy (What is epilepsy?) and. Location: INDIA , 16 years of age, Patient experienced the following unwanted or unexpected effects: insomnia, muscle tightness, osteomalacia, pain in extremity, restless legs syndrome.

6755970-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blister, Conjunctival Hyperaemia, Discomfort, Erythema, Eye Discharge, Feeling Cold
on May 24, 2010 Female patient from CHINA , 36 years of age, was diagnosed with herpes zoster and was treated with Carbamazepine (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blister, conjunctival hyperaemia, discomfort, erythema, eye discharge, feeling cold. Carbamazepine dosage: Unk,unk. Patient was hospitalized.

6755951-X | Dyslipidaemia
on May 21, 2010 Male patient from GERMANY , 33 years of age, weighting 264.6 lb, was diagnosed with epilepsy (What is epilepsy?), type 2 diabetes mellitus, dyslipidaemia and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: dyslipidaemia. Carbamazepine dosage: 0.5-0 Df/daily. During the same period patient was treated with TIMOX (600 Mg, Unk) (View Timox Review and Timox Label ), METFORMIN (500 Mg, Unk) (View Metformin Review and Metformin Label ), LAMOTRIGINE (200 Mg, Unk) (View Lamotrigine Review and Lamotrigine Label ), BEZAFIBRATE (400 Mg, Daily) (View Bezafibrate Review and Bezafibrate Label ), LANTUS (26 Iu, Unk) (View Lantus Review and Lantus Label ).

6754938-0 | Dystonia
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?) on May 15, 2010 from NIGERIA Additional patient health information: Male patient , 31 years of age, was diagnosed with partial seizures and. Carbamazepine dosage: 200 Mg, Bid.

6754674-0 | Hyperlipidaemia
Adverse event was reported on May 21, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 0.5-0-1 Df/d) was diagnosed with epilepsy (What is epilepsy?), type 2 diabetes mellitus, dyslipidaemia and. Location: GERMANY , 33 years of age, weighting 264.6 lb, Patient had the following side effects: hyperlipidaemia. During the same period patient was treated with LAMOTRIGINE (0.5-0-0. Df/d) (View Lamotrigine Review and Lamotrigine Label ), METFORMIN (Daily Dose: 2 Df Dosage Form Every Day) (View Metformin Review and Metformin Label ), BEZAFIBRAT (Daily Dose: 400 Mg Milligram(s) Every Day) (View Bezafibrat Review and Bezafibrat Label ), TIMOX /00371202/ (0.5-0-1 Df/d) (View Timox /00371202/ Review and Timox /00371202/ Label ), LANTUS /01483501/ (Daily Dose: 26 Iu International Unit(s) Every Day) (View Lantus /01483501/ Review and Lantus /01483501/ Label ).

6754673-9 | Hyperlipidaemia
on May 21, 2010 Male patient from GERMANY , 33 years of age, weighting 264.6 lb, was diagnosed with epilepsy (What is epilepsy?), type 2 diabetes mellitus, dyslipidaemia and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: hyperlipidaemia. Carbamazepine dosage: 0.5-0-1 Df/d. During the same period patient was treated with LAMOTRIGINE (0.5-0-0. Df/d) (View Lamotrigine Review and Lamotrigine Label ), METFORMIN (Daily Dose: 2 Df Dosage Form Every Day) (View Metformin Review and Metformin Label ), BEZAFIBRAT (Daily Dose: 400 Mg Milligram(s) Every Day) (View Bezafibrat Review and Bezafibrat Label ), TIMOX /00371202/ (0.5-0-1 Df/d) (View Timox /00371202/ Review and Timox /00371202/ Label ), LANTUS /01483501/ (Daily Dose: 26 Iu International Unit(s) Every Day) (View Lantus /01483501/ Review and Lantus /01483501/ Label ).

6754669-7 | Hyperlipidaemia
on May 21, 2010 Male patient from GERMANY , 33 years of age, weighting 264.6 lb, was diagnosed with epilepsy (What is epilepsy?), type 2 diabetes mellitus, dyslipidaemia and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlipidaemia. Carbamazepine dosage: 0.5-0-1 Df/d. During the same period patient was treated with LAMOTRIGINE (0.5-0-0. Df/d) (View Lamotrigine Review and Lamotrigine Label ), METFORMIN (Daily Dose: 2 Df Dosage Form Every Day) (View Metformin Review and Metformin Label ), BEZAFIBRAT (Daily Dose: 400 Mg Milligram(s) Every Day) (View Bezafibrat Review and Bezafibrat Label ), TIMOX /00371202/ (0.5-0-1 Df/d) (View Timox /00371202/ Review and Timox /00371202/ Label ), LANTUS /01483501/ (Daily Dose: 26 Iu International Unit(s) Every Day) (View Lantus /01483501/ Review and Lantus /01483501/ Label ).

6754668-5 | Hyperlipidaemia
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: hyperlipidaemia on May 21, 2010 from GERMANY Additional patient health information: Male patient , 33 years of age, weighting 264.6 lb, was diagnosed with epilepsy (What is epilepsy?), type 2 diabetes mellitus, dyslipidaemia and. Carbamazepine dosage: 0.5-0-1 Df/d. During the same period patient was treated with LAMOTRIGINE (0.5-0-0. Df/d) (View Lamotrigine Review and Lamotrigine Label ), METFORMIN (Daily Dose: 2 Df Dosage Form Every Day) (View Metformin Review and Metformin Label ), BEZAFIBRAT (Daily Dose: 400 Mg Milligram(s) Every Day) (View Bezafibrat Review and Bezafibrat Label ), TIMOX /00371202/ (0.5-0-1 Df/d) (View Timox /00371202/ Review and Timox /00371202/ Label ), LANTUS /01483501/ (Daily Dose: 26 Iu International Unit(s) Every Day) (View Lantus /01483501/ Review and Lantus /01483501/ Label ).

6754139-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cytomegalovirus Test Positive, Gamma-glutamyltransferase Increased, Red Blood Cell Count Decreased, Roseolovirus Test Positive, Skin Test Positive
Adverse event was reported on May 25, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: Oral) was diagnosed with temporal lobe epilepsy and. Location: JAPAN , 34 years of age, After Carbamazepine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cytomegalovirus test positive, gamma-glutamyltransferase increased, red blood cell count decreased, roseolovirus test positive, skin test positive. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6754134-7 | Condition Aggravated, Confusional State, Epilepsy, Fall, Myoclonus
on May 17, 2010 Female patient from FRANCE , 76 years of age, was diagnosed with myoclonic epilepsy and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, confusional state, epilepsy (What is epilepsy?), fall (What is fall?), myoclonus. Carbamazepine dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

6754128-1 | Depressive Symptom, Disease Progression, Mania, Psoriasis
on May 24, 2010 Female patient from GREECE , weighting 176.4 lb, was treated with Carbamazepine (View Usage). Patient had the following side effects: depressive symptom, disease progression, mania, psoriasis. Carbamazepine dosage: 800 Mg (400 Mg,2 In 1 D).

6753105-4 | Dysarthria, Glossodynia
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: dysarthria, glossodynia on May 24, 2010 from CHINA Additional patient health information: Female patient , 87 years of age, . Carbamazepine dosage: 200 Mg, Bid. During the same period patient was treated with METHYLCOBALAMIN (View Methylcobalamin Review and Methylcobalamin Label ), NOVOLIN R (38 U, Qd) (View Novolin R Review and Novolin R Label ).

6753086-3 | Blister, Flushing, Lip Swelling, Scab, Skin Exfoliation
Adverse event was reported on May 24, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 100 Mg, Bid) was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Location: CHINA , 42 years of age, Patient experienced the following unwanted or unexpected effects: blister, flushing, lip swelling, scab (What is scab?), skin exfoliation. Patient was hospitalized.

6751602-9 | Abdominal Pain, Acute Hepatic Failure, Balance Disorder, Cerebellar Syndrome, Diplopia, Gait Disturbance
on May 14, 2010 Male patient from CANADA , 34 years of age, was diagnosed with complex partial seizures, back pain (What is back pain?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), acute hepatic failure, balance disorder, cerebellar syndrome, diplopia, gait disturbance. Carbamazepine dosage: 1600 Mg;qd. During the same period patient was treated with ACETAMINOPHEN (2000 Mg;qd, 2500 Mg) (View Acetaminophen Review and Acetaminophen Label ), CLOBAZAM (CLOBAZAM) (View Clobazam (clobazam) Review and Clobazam (clobazam) Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ). Patient was hospitalized.

6750939-7 | Epstein-barr Virus Infection
on May 19, 2010 Male patient from ITALY , child 8 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: epstein-barr virus infection. Carbamazepine dosage: . Patient was hospitalized.

6750609-5 | Grand Mal Convulsion, Myoclonus, Psychomotor Skills Impaired, Somnolence
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, myoclonus, psychomotor skills impaired, somnolence on May 18, 2010 from FRANCE Additional patient health information: Female patient , 76 years of age, was diagnosed with myoclonic epilepsy, parkinson's disease (What is parkinson's disease?) and. Carbamazepine dosage: Dose Increased After The First Hospital Admission. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

6750581-8 | Grand Mal Convulsion, Myoclonus, Psychomotor Skills Impaired, Somnolence
Adverse event was reported on May 18, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: Dose Increased After The First Hospital Admission) was diagnosed with myoclonic epilepsy, parkinson's disease (What is parkinson's disease?) and. Location: FRANCE , 76 years of age, Patient had the following side effects: grand mal convulsion, myoclonus, psychomotor skills impaired, somnolence. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

6750580-6 | Grand Mal Convulsion, Myoclonus, Psychomotor Skills Impaired, Somnolence
on May 18, 2010 Female patient from FRANCE , 76 years of age, was diagnosed with myoclonic epilepsy, parkinson's disease (What is parkinson's disease?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: grand mal convulsion, myoclonus, psychomotor skills impaired, somnolence. Carbamazepine dosage: Dose Increased After The First Hospital Admission. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

6749550-3 | Extrapyramidal Disorder
on May 17, 2010 Male patient from SPAIN , 62 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder. Carbamazepine dosage: 600 Mg. During the same period patient was treated with LITHIUM CARBONATE (800 Mg) (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

6748796-8 | Cataract Cortical, Convulsion, Grand Mal Convulsion, Visual Acuity Reduced
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: cataract cortical, convulsion, grand mal convulsion, visual acuity reduced on May 20, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 38 years of age, was diagnosed with temporal lobe epilepsy and. Carbamazepine dosage: 600-800 Mg, Per Day. Patient was hospitalized.

6748777-4 | Brain Operation, Cerebellar Atrophy, Convulsion, Nervous System Disorder
Adverse event was reported on May 20, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: Unk) . Location: UNITED STATES , child 11 years of age, After Carbamazepine was administered, patient had the following side effects: brain operation, cerebellar atrophy, convulsion, nervous system disorder. During the same period patient was treated with LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), PHENYTOIN (Unk) (View Phenytoin Review and Phenytoin Label ), VALPROIC ACID (Unk) (View Valproic Acid Review and Valproic Acid Label ), IMMUNE GLOBULIN (HUMAN) (View Immune Globulin (human) Review and Immune Globulin (human) Label ).

6748700-2 | Abdominal Tenderness, Breath Sounds Abnormal, Conjunctival Erosion, Cough, Dermatitis Exfoliative, Dyskinesia, Effusion, Erythema
on May 17, 2010 Female patient from CHINA , 17 years of age, was diagnosed with convulsion and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal tenderness, breath sounds abnormal, conjunctival erosion, cough, dermatitis exfoliative, dyskinesia, effusion, erythema. Carbamazepine dosage: . Patient was hospitalized.

6744505-7 | Confusional State, Fall, Gastrointestinal Haemorrhage, Herpes Zoster, No Therapeutic Response, Pneumonia Aspiration, Respiratory Depression, Respiratory Distress
on May 26, 2010 Male patient from UNITED STATES , weighting 150.4 lb, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?), post herpetic neuralgia and was treated with Carbamazepine (View Usage). Patient had the following side effects: confusional state, fall (What is fall?), gastrointestinal haemorrhage, herpes zoster, no therapeutic response, pneumonia aspiration, respiratory depression, respiratory distress. Carbamazepine dosage: Tid Oral/peg. During the same period patient was treated with GABAPENTIN (Tid Peg) (View Gabapentin Review and Gabapentin Label ), ZYVOX (View Zyvox Review and Zyvox Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TIGECYCLINE (View Tigecycline Review and Tigecycline Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), ZOSYN (View Zosyn Review and Zosyn Label ). Patient was hospitalized.

6743473-1 | Fall
Patient was taking Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: fall (What is fall?) on May 14, 2010 from GERMANY Additional patient health information: Female patient , 78 years of age, was diagnosed with diabetic neuropathy, sleep disorder (What is sleep disorder?), restlessness, prophylaxis, coronary artery disease (What is coronary artery disease?), anaemia, oedema peripheral, cardiac failure, hyperuricaemia and. Carbamazepine dosage: . During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), DOXEPIN HCL (Daily Dose: 1 Df Dosage Form Every Days) (View Doxepin Hcl Review and Doxepin Hcl Label ), PANTOPRAZOLE (Daily Dose: 1 Df Dosage Form Every Days) (View Pantoprazole Review and Pantoprazole Label ), ASPIRIN (Daily Dose: 1 Df Dosage Form Every Days) (View Aspirin Review and Aspirin Label ), FERRO SANOL /00023503/ (Daily Dose: 1 Df Dosage Form Every Days) (View Ferro Sanol /00023503/ Review and Ferro Sanol /00023503/ Label ), FURORESE (View Furorese Review and Furorese Label ), BISOHEXAL /00802602/ (View Bisohexal /00802602/ Review and Bisohexal /00802602/ Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6743426-3 | Influenza Like Illness, Malaise, Pharyngitis
Adverse event was reported on May 18, 2010 by a Female patient taking Carbamazepine (View Usage) (Dosage: Unk,unk) . Location: FRANCE , 43 years of age, Patient experienced the following unwanted or unexpected effects: influenza like illness, malaise, pharyngitis. During the same period patient was treated with AMOXICILLIN (Received From Day 2 To Day 9) (View Amoxicillin Review and Amoxicillin Label ).

6742773-9 | Convulsion
on May 07, 2010 Male patient from UNITED STATES , weighting 202.0 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Carbamazepine (View Usage). Patient had the following side effects: convulsion. Carbamazepine dosage: 200 Mg Twice Daily Oral. During the same period patient was treated with MULTIVITAMIN DAILY (View Multivitamin Daily Review and Multivitamin Daily Label ).

6742065-8 | Growth Retardation, Hypospadias
on May 24, 2010 Male patient from ITALY , child 7 years of age, weighting 36.38 lb, was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: growth retardation, hypospadias. Carbamazepine dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6739846-3 | Abasia, Ataxia, Bradykinesia, Clonus, Gait Disturbance, Intention Tremor, Positive Rombergism
Patient was taking Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, ataxia (What is ataxia?), bradykinesia, clonus, gait disturbance, intention tremor, positive rombergism on May 13, 2010 from SPAIN Additional patient health information: Male patient , 62 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Carbamazepine dosage: 600 Mg Daily. During the same period patient was treated with LITHIUM CARBONATE (800 Mg Daily) (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

6739055-8 | Stevens-johnson Syndrome
Adverse event was reported on May 24, 2010 by a Male patient taking Carbamazepine (View Usage) (Dosage: 1 Tablet Each Time Twice Daily Po) was diagnosed with headache (What is headache?), hypoaesthesia facial and. Location: UNITED STATES , 57 years of age, weighting 132.3 lb, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ). Patient was hospitalized.

6738394-4 | Abdominal Pain, Acute Hepatic Failure, Balance Disorder, Diplopia, Gait Disturbance, Renal Failure Acute, Tubulointerstitial Nephritis
on May 06, 2010 Male patient from CANADA , 34 years of age, was diagnosed with complex partial seizures, back pain (What is back pain?) and was treated with Carbamazepine (View Usage). After Carbamazepine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), acute hepatic failure, balance disorder, diplopia, gait disturbance, renal failure acute, tubulointerstitial nephritis. Carbamazepine dosage: 1600 Mg; Qd. During the same period patient was treated with ACETAMINOPHEN (2500 Mg; 2000 Mg;qd) (View Acetaminophen Review and Acetaminophen Label ), CLOBAZAM (View Clobazam Review and Clobazam Label ), METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ). Patient was hospitalized.

6737712-0 | Akathisia, Anxiety, Extrapyramidal Disorder, Fatigue, Lethargy, Overdose, Parkinsonian Rest Tremor, Suicide Attempt
on May 09, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with schizoaffective disorder and was treated with Carbamazepine (View Usage). Patient experienced the following unwanted or unexpected effects: akathisia, anxiety (What is anxiety?), extrapyramidal disorder, fatigue, lethargy, overdose, parkinsonian rest tremor, suicide attempt. Carbamazepine dosage: 1200 Mg (600 Mg, 2 In 1 D). During the same period patient was treated with ABILIFY (15 Mg (15 Mg, 1 In 1 D)) (View Abilify Review and Abilify Label ), VISTARIL (View Vistaril Review and Vistaril Label ). Patient was hospitalized.

6736738-0 | Pharyngitis, Rash, Skin Test Positive
Patient was taking Carbamazepine (View Usage). Patient had the following side effects: pharyngitis, rash (What is rash?), skin test positive on May 18, 2010 from FRANCE Additional patient health information: Female patient , 17 years of age, . Carbamazepine dosage: Unk, Unk. During the same period patient was treated with AMOXICILLIN (Unk, Unk) (View Amoxicillin Review and Amoxicillin Label ).